SENSEX    74339.44       486.50    |    NIFTY    22570.35       167.95 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
HCL Tech, Rainbow Children's Medicare, Aarti Drugs in focus
10-May-22   08:40 Hrs IST

HCL Technologies (HCL): The IT major announced a strategic partnership with Syniti. This collaboration with Syniti, a global leader in enterprise data management that combines AI-driven software and data expertise, will help develop industry-specific data solutions and deliver higher quality SAP S/4HANA transformations.

Rainbow Children's Medicare: Shares of Rainbow Children's Medicare will debut on the bourses today, 10 May 2022. The company sold its shares in the range of Rs 516-542 apiece.

Aarti Drugs: The company reported 7.1% rise in consolidated net profit to Rs 55.34 crore in Q4 FY22 from Rs 51.65 crore posted in Q4 FY21. The company's consolidated net sales jumped 38.4% to Rs 694.27 crore in Q4 FY22 compared to Rs 501.75 in Q4 FY21. Profit before tax rose 8% year on year to Rs 70.5 crore in Q4 FY22.

SRF: SRF reported 59% increase in consolidated net profit to Rs 606 crore on a 36% rise in revenue to Rs 3,549 crore in Q4 FY22 as compared with corresponding period last year (CPLY).

KEI Industries: The company posted consolidated net profit of Rs 115.98 crore in Q4 FY22 from Rs 86.18 crore registered in Q4 FY21. Net sales rose to Rs 1791.71 crore in Q4 FY22 from Rs 1246.30 crore posted in Q4 FY21.

Bhageria Industries: The company has received an environment clearance for setting up manufacturing plant of 'Synthetic Organic Chemicals' [API-Bulk Drug and it's Intermediates] at GIDC Estate Vapi, Dist. Valsad.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.96 1.07
United Kingdom (GBP) 1.16 1.00 103.28 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.31 1.00
Market News << ALL News
  25-Apr-2024, (05:52 )  IndusInd Bank Q4 PAT..
  25-Apr-2024, (04:53 )  Tech Mahindra Q4 PAT..
  25-Apr-2024, (04:33 )  Laurus Labs slides a..
  25-Apr-2024, (04:32 )  ACC records four-fol..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)